Cancer Genetics

Article	Citations
84. Continued utility of chromosome analysis for plasma cell disorders	503
93. Enhancing cytogenetic abnormality detection through flow cytometry-guided B-Cell stimulated cultures	137
34. Best practices for testing low-level mosaic variants:Recommendations from CGC somatic overgrowth and vascular anomalies working group	85
24. Prediction of gene expression in NSCLC tumors and their microenvironment using an explainable machine learning model	62
77. Cytogenomic characterization of ALK-negative ALCL cell lines DL-40 and Fe-PD	50
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures	49
27. Five-year experience of evaluating individuals at-risk for underlying genetic predisposition to hematologic malignancy	45
96. A unique case presentation of pediatric spinal ependymoma with chromothripsis of chromosome 6: case report	39
58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.	33
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience	33
64. A rare finding of triple KRAS mutations with OmniSeq® INSIGHT in a patient with colorectal adenocarcinoma	30
43. Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation	26
40. Prioritization of defining and supportive diagnostic variants in pediatric tumors	26
2. Diagnostic next generation sequencing to detect MYD88 L265P in lymphoplasmacytic lymphoma compared to ddPCR	25
Detection of VHL variant on multigene panel testing for hereditary breast cancer: Implications for genetic counselling	24
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study	23
Plasma cell-free DNA biomarkers as novel diagnostic and prognostic tools in breast cancer	22
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway	18
Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case	18
Exploring the role of transcription factor TWIST1 in bladder cancer progression	14
Context-specific roles of DDX60 in colorectal cancer via autophagy regulation and DDX58 signaling	14
Upregulation of Uracil DNA Glycosylase (UNG) in Prostate Cancer	14
The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line	14
94. Novel rare atypical e8a2 BCR::ABL1 fusion transcript detected in a patient with chronic myeloid leukemia (CML)	14
15. Clinical impact of in-house molecular testing for underserved cancer patients in southern Alabama	12

36. Significant copy number variants and loss of heterozygosity in Wilms Tumor: Insights from Nationwide Pediatric Oncology	12
Expression and clinical significance of the imprinted gene PHLDA2 in colorectal cancer	12
Comprehensive analysis of PLKs expression and prognosis in breast cancer	12
13. HPV forms chimeric virus-human transcripts that affect host gene expression in cervical tumors	12
Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)	12
70. Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia	11
56. Variants of established clinical significance: Progress and challenges in the VECS SC-VCEP	11
99. Histopathologic Correlation Somatic Variants in Non Small Cell Lung Cancer with High Tumor Mutation Burden	11
Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature	11
102. Using cytogenomics to distinguish two types of renal cell carcinoma in a composite or collision tumor	10
3. Application of optical genome mapping to identify samples with homologous recombination deficiency	10
104. A hematologic case with germline deletion of PMS2 and increased risk of HNPCC studied by optical genome mapping and NGS	10
61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma	10
14. Concurrent systemic mastocytosis and T-lymphoblastic lymphoma unified by a novel cryptic JAKMIP2::PDGFRB rearrangement	10
4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia	10
129. Standardization of cancer terminology in the Mondo Disease Ontology	10
17. Deconvolution of genetic heterogeneity in Glioblastoma using multi-region sampling	10
74. Genetic and functional characterization of complex chromosomal rearrangements in a family with multisystem anomalies	10
Corrigendum to “Study on the Anticancer Mechanism of Hydroxygenkwanin in Esophageal Cancer via the ESRRA Signaling Pathway” [Cancer Genetics, 298–299, (2025) Pages 180-192]	9
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues	9
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia	9
Germline APC I1307K and MITF E318K variants in a patient with high-grade serous ovarian carcinoma: A case report	9
8. Harnessing the power of microarray in the analysis of rarer pediatric sarcomas	9
Three FGFR4 gene polymorphisms contribute to the susceptibility of urethral cancer in the middle and south of Iraq population	9
16. International working group recommendations for the implementation of optical genome mapping in Hematologic Malignancies	9
71. Improved tumor profiling and diagnosis via long-read variant detection toolkit	8
Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma	8
60. AI-guided histopathology predicts brain metastasis in lung cancer patients	8
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer	8
Ewing sarcoma of the rib with a rare PTEN mutation	8
The multidimensional role of laminin γ2 (LAMC2) on cancer progression	8
38. Decoding the genetic complexity of B-ALL through long-read and RNA sequencing methods	8
Corrigendum to “Ultra-sensitive detection of melanoma NRAS mutant ctDNA based on programmable endonucleases” [Cancer Genetics 294-295 (2025) 47–56]	8
Mutation status in yes-associated protein 1 (YAP1) in an insulinoma cell line Rin-5F	8
A complex t(15;22;17)(q22;q11.2;q21) variant of APL	8
22. Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients treated with AR-directed therapy	7
79. Implications of fortuitous detection of JAK2 V617F mutations with solid tumor clinical sequencing	7
37. Epigenetic reprogramming of brain development pathways during non-small cell lung cancer metastasis to brain	7
Prognosis prediction and drug guidance of ovarian serous cystadenocarcinoma through mitochondria gene-based model	7
76. Goals, methods and challenges in a clinical validation of a NGS-based platform for the detection of constitutional CNVs	7
18. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia	7
7. Overview of recurrent and novel gene fusions detected in a clinical diagnostic laboratory	6
Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia	6
139. Feasibility of comprehensive whole genome profiling in hematological malignancies	6
53. Uveal melanoma - The New Zealand perspective	6
38. Formation of a tumor-specific gene list: The Central Nervous System (CNS) tumor taskforce experience	6
63. Comparative analysis of testing methods used for the detection of internal tandem duplications in the KMT2A/MLL gene	6
9. Best practices for testing and reporting of FISH studies in multiple myeloma: Recommendations from the CGC working group	6
55. Evaluation of RNA quality and quantity for optimizing RNA-based NGS testing	5
Corrigendum to “Omics approaches: Role in acute myeloid leukemia biomarker discovery and therapy” [Cancer Genetics, 2025, Volume: 292-293, Pages: 14-26/https://doi.org/10.1016/j.cancergen.2024.12.006]	5

50. Updates to the CIViC knowledgebase: The fusion feature type	5
Editorial Board	5
64. Machine learning-based genomic subgrouping to refine chemo decisions in low-risk ER+/HER2- breast cancer	5
24. Tissue-based sequencing for laboratory diagnosis of Somatic Mosaic Disorders	4
Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.	4
66. Optical genome mapping workflow for Somatic Abnormality detection in Multiple Solid Tumor types	4
Malignant psammomatous melanotic schwannoma in a patient with Carney complex associated with a novel variant in the PRKAR1A gene	4
94. Initial efforts of the ClinGen Solid Tumor Taskforce in promoting variant curation in solid tumors into CIViC	4
Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma	4
61. Familial Wilms Tumor with a novel XPO5 germline variant	4
77. dic(7;9):A distinct entity in B-ALL with multiple genomic aberrations including IKAROS and PAX5	4
120. Expert curation of FLT3 variants by the ClinGen FLT3 Somatic Cancer Variant Curation expert panel	4
9. Clinical utility of optical genome mapping (OGM) for B-cell acute lymphoblastic leukemia (B-ALL)	4
Rare and potentially fatal ‐ Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children	4
65. Insights into the genetic heterogeneity of glioblastoma: gene amplification in ecDNA and HSR	4
Editorial Board	4
Clinical management of TP53 mosaic variants found on germline genetic testing	4
2. Clinical, cytogenetic and genomic profiling of B-Other Acute Lymphoblastic Leukemia: An Indian cohort study	4
LncRNA SNHG29 Suppresses Epithelial Ovarian Cancer Cell Invasion and Migration via miR-20b-3p/GNAI3 Axis Regulation	4
A novel in vitro colorectal cancer model for investigating ABCB1- and ABCC1-mediated multidrug resistance	4
Editorial Board	4
77. Mining COSMIC for frameshift neoantigens as `off-the-shelf' therapeutic cancer vaccine candidates	4
31. A cross-consortia initiative for aligning the definitions and descriptions of gene fusions	4
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cells	3
15. Genomic Proximity Mapping (GPM): Evaluation of a next generation cytogenomic assay for acute myeloid leukemia	3
Unraveling complex karyotype clonal architecture: co-existing double TP53 mutations alongside DNMT3A, TET2, and NF1 mutations – a case study	3
Clonal cytogenetic abnormality in IgG4-related disease	3
127. Characterization of alternative transcription start and termination sites in glioblastoma	3
Outcomes of multigene panel testing for hereditary cancer in two Israeli medical centers 2013–2024	3
39. Rare TBL1XR1::JAK2 fusion in a patient with pediatric T-ALL identified by optical genome mapping & long-read sequencing	3
7. AI-Based Algorithms for neoplastic metaphase cells boost efficiencies in the cytogenetics laboratory	3
28. Analytical validation of an optical genome mapping assay for structural variant detection in hematologic malignancies	3
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, Rigshospitalet	3
Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathway	3
30. Semi-automated approaches for digital pathology analyses standardize pathologic assessment of clinical melanoma biopsies	3
45. Clonal hematopoiesis in childhood cancer survivors	3
A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists	3
24. Clinical utility of optical genome mapping: comparison with standard cytogenomics work-up for hematological malignancies	3
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation	3
11. Impact of long-term plasma storage on cell free dna biomarker studies	3
93. Surveying the genomic landscape of Mantle Cell Lymphoma	3
Metabolic–related gene signatures for survival prediction and immune cell subtypes associated with prognosis in intrahepatic cholangiocarcinoma	3
78. Next generation cytogenomics improves patient risk stratification in acute myeloid leukemia	3
44. Novel ENOX2::RUNX1 fusion in a case of acute myeloid leukemia-myelodysplasia-related detected by optical genome mapping	3
Corrigendum to “RNF121 Promotes the Proliferation, Migration, and Invasion of Non-Small-Cell lung cancer cell lines” [Cancer Genetics 298-299 (2025) 193-197]	3
Editorial Board	3
75. Clinical implementation of a precision medicine consultation service	3
9. The dual PI3K inhibitor duvelisib potently inhibits cytokine release syndrome while maintaining CAR-T function	3
41. BRAF mutations blood and bone marrow samples of langerhans cell histiocytosis patients with CNS involvement	3
In silico protein structural analysis of PRMT5 and RUVBL1 mutations arising in human cancers	3
98. A bioinformatics analysis of differentially expressed genes in non-small cell lung cancer subtypes	3
21. Translating human readable variation descriptions to unique computable variations with the Variation Normalizer	3
74. Dilemma of selecting the optimal diagnostic test(s) for genetic biomarkers in hematologic malignancies	2
ADAR1 gene expression and its importance in breast cancer	2
Composite mantle cell lymphoma with cryptic ins(11;2)(q13;p11.2p11.2)/IGK::CCND1 and lymphoplasmacytic lymphoma with MYD88 L265P mutation	2
24. Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics	2
1. Enrichment of Hodgkin and Reed-Sternberg (HRS) cells using size-based microfiltration	2
41. Step 2 updates for the oncogenic assessment of FLT3 variants by the ClinGen FLT3 somatic cancer variant curation expert	2
56. Clonal 6p loss of heterozygosity in hematolymphoid neoplasms as the sole finding at diagnosis	2
SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1	2
43. Association between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes	2
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma	2
Potential use of SCAT1, SCAT2, and SCAT8 as diagnostic and prognosis markers in colorectal cancer	2
83. Cytogenetic and molecular characterization of IDH-mutant adult-type diffuse gliomas with near-total 1p/19q co-deletions	2
134. Novel fusions in aggressive infant sarcomas: Expanding the scope of 'CIC-rearranged' sarcoma without CIC rearrangement	2
Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patients	2
Mesothelin CAR‐T cells secreting PD‐L1 blocking scFv for pancreatic cancer treatment	2
Biological landscape of human papilloma virus-related head and neck cancer according to virus genotype	2
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy	2
Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion)	2
Persistent monosomy 7 in Philadelphia chromosome-negative cells without disease progression over nearly two decades of follow-up in chronic myeloid leukemia	2
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer	2
55. Clinical validation and implementation of exome, transcriptome and whole genome sequencing for pediatric cancers	2
103. Formation of a ClinGen Variant Curation Expert Panel (VCEP) dedicated to Oncohistone H3 Variants in Pediatric Gliomas	2
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant	2
DNA quality challenges in breast cancer samples from three low-middle income African countries: a straightforward protocol for research in cancer genomics	2
89. TCF3::ZNF384 in a Peruvian girl with mixed-phenotype acute leukemia and poor treatment outcome	2
66. Screening for genetic predisposition to pediatric leukemia in a Peruvian population	2
Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 pre-B-cell acute lymphoblastic leukemia	2
Mechanistic study of Liquiritigenin inhibiting bladder cancer cell proliferation and migration by regulating STING1	2

79. Utilization of molecular sequencing and CMA to identify a novel variant in recurrent hydrops fetalis	2
Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma	2
Villin1 predicts survival and adjuvant TACE response in hepatocellular carcinoma	2
7. Application of expert panel-derived oncogenicity guidelines in BCR::ABL1-like B-lymphoblastic leukemia/lymphoma	2
68. Orthogonal approaches to validate a knowledgebase of interpretations of clinically relevant somatic cancer variants	2
46. Integrative cytogenetic and molecular studies unmasks `chromosomal mimicry' in hematologic malignancies	2
The role of miR-10b-5p in prostate cancer and its exosome-mediated angiogenesis effect	2
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia	2
38. Assessment of TRG and TRB clonality by NGS of dermatologic specimens is impacted by biopsy type, DNA and amplicon sizes	2
48. Targeted RNA-Seq on fresh frozen and methanol/acetic acid fixed cells in diagnostic workup of hematologic malignancies	2
5. Implementation of Automatic Slide Processing for Aneuploidy FISH Test	1
45. Characterizing complex Non-IG gene rearrangements in high-grade B-Cell lymphoma: Insights from FISH and karyotyping	1
16. Comparative analysis of targeted RNA-Seq and optical genome mapping for detecting clinically significant gene rearrangements	1
1. Rare oncogenic structural variations in FGFR genes in childhood brain tumors provide potential therapeutic targets	1
130. The Myeloid Malignancy Variant Curation Expert Panel: Investigating RUNX1, GATA2, and DDX41	1
Acute cardiac dysfunction in patients with ovarian cancer treated with Niraparib due to TFAM mutation: A case series and functional analysis	1
Evaluating the consistency of SMARCB1 variant classification and assertions of genotype-phenotype relationships in ClinVar	1
94. Comparison of FISH to whole exome/whole transcriptome detection of relevant structural alterations in Multiple Myeloma	1
Two MLN-TK patients with ETV::ABL1 fusions mediated by different mechanisms with false negative FISH results resolved with RNA fusion analysis	1
63. A female-specific chimeric RNA with differential expression in COVID patients	1
5. Overcoming challenges in semantic alignment of therapeutics knowledge using TheraPy	1
2. Chromothripsis in meningiomas is associated with more aggressive behavior	1
128. Clinical testing of mismatch repair in neoplasms using multiple laboratory methods	1
10. Current state of diagnostic testing in pediatric sarcoma: practical solutions to diagnostic challenges	1
Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients	1
32. Whole transcriptome sequencing as a diagnostic tool for AML	1
63. Creation and validation of a new in silico reference model file for SNP array testing on melanocytic neoplasms	1
The mechanism of lncRNA SSTR5-AS1 promoting ferroptosis resistance and immune escape in ovarian cancer cells by recruiting STAT3 to regulate SLC7A11 expression	1
Over‐expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells	1
133. Incidental finding of the 1st degree of parental relatedness in a newborn with JBS and homozygous UBR1 mutation	1
20. Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric solid tumors	1
Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model	1
105. Clinical whole-genome sequencing identifies NSD3 as the correct fusion partner of NUP98 in a patient with acute myeloid	1
90. TERT promoter mutation detection by ddPCR in glial atypia	1
The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer	1
100. Ultrasensitive molecular residue disease detection enabled by genome wide concatemer error correction	1
67. Biomarker discovery and gene therapy approaches for triple negative breast cancer risk in African American women	1
92. The good, the bad, and the mysterious: Complexity in identifying the cause of a holoprosencephaly case	1
12. Contextualizing clinical significance using FDA label supplemented DGI data	1
83. Quantum lattices for early cancer detection through machine learning	1
85. Microfilter enrichment of Hodgkin and Reed-Sternberg (HRS) cells	1
44. UMI-based expanded NGS panel in precision molecular diagnosis of vascular anomalies: Early results	1
36. Clinical utility of copy number alteration analysis in the evaluation of Melanocytic Lesions for diagnosis and prognosis	1
Whole genome joint analysis reveals ATM:C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer	1
30. Current next generation sequencing reporting practices: A GOAL Consortium report	1
62. Characterization of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with KMT2A amplification	1
70. Assessment of circulating tumor DNA tumor mutational burden to define resistance in HR+ HER2- metastatic breast cancer	1
The impact of extracellular vesicles on breast cancer metastasis and therapeutics: genetic considerations	1
Regulator of G-protein signaling 14 (RGS14) promotes cancer growth in hepatocellular carcinoma	1
15. ClinGen Somatic Cancer expert curation panel for FGFR genes in Genitourinary Cancer	1
16. ClinGen Cancer Variant Interpretation (CVI) Committee: Pilot guidance for somatic cancer variant curation expert panels	1
78. Identification of a non-productive KMT2A rearrangement in B-ALL with apparent concurrent ETV6::RUNX1 and KMT2A fusions	1
90. Assessment of conflicts in hereditary cancer genetic test interpretations between ClinGen and US clinical laboratories	1
Ellagic acid inhibits EZH2: a potential epigenetic therapeutic molecule for cancer	1
91. Atypical BCR::ABL1 rearrangements identified by optical genome mapping in patients with chronic myeloid leukemia	1
Synchronous driver gene alterations (EGFR L858R, T790M, and ROS1) rearrangements in a patient with early-stage lung adenocarcinoma	1
11. Evaluation of Hi-C versus optical genome mapping for diagnosing constitutional genomic structural variants	1
137. Estimation of familial DNA contamination using Mendelian inconsistencies from next generation sequencing of trios	1
Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma	1
138. Optical Genome Mapping workflow for identification and analysis of variants in Hematological Malignancies	1
High YEATS4 expression characterizes MDM2-amplified liposarcoma	1
Downregulation of FAM134B suppresses thyroid cell carcinoma development by modulating endoplasmic reticulum stress and autophagy	1
81. Discrepancies in the detection of PML::RARA gene rearrangement by FISH using commonly used dual-color dual-fusion probes	1
10. Optical genome mapping on pediatric leukemia samples: A single hospital experience	1
Influence of IL-38 as a novel biomarker on the pathophysiological processes of esophageal cancer	1
The effect of HOTAIR gene variants on the development of bladder cancer and its clinicopathological characteristics in a Caucasian population	1
57. Not just iron deficiency: Occult GI bleeding as the first clue to indolent mantle cell lymphoma	1
107. MyVariant.info: a gateway to integrated resource of variant annotations	1
45. Examining potential candidate genes within deletions of 3p14.2 to 3p14.1 in two cases of autism and developmental delay	1
43. Fusion Curation Interface: an educational tool to explore a unified framework for representing & curating gene fusions	1
125. Expect the unexpected? Microarray analyses of pediatric tumors	1
23. Prediction of BRAF V600 mutation status in cutaneous melanoma using an explainable deep learning model	1
50. Molecular profiling of Cytolyt-Fixed FNA washes to improve diagnostic yield in lung cancer	1
Editorial Board	1
25. Improving fusion detection sensitivity in the TruSight Oncology 500 Panel through DNA-based structural variant analysis	1
82. Can mitochondrial DNA mutations be used as a biomarker for endometrial cancer?	1
114. Comparison of optical genome mapping, CMA, and 523-gene NGS panel for Homologous Recombination Deficiency calculation	1
TRIM29 promotes glioblastoma progression via ubiquitinating NEFL and activating the PI3K/AKT signaling pathway	1
59. BRCA1 mutated high grade serous ovarian cancer showing strong response to PARP inhibitors and ctDNA MRD monitoring	1
Mismatch Repair Cancer Syndrome presenting as synchronous high-grade glioma and diffuse large B cell lymphoma in a pediatric patient	1
65. Creating a common language for categorical variants	1
31. Automated fluorescence in situ hybridization (FISH) imaging and analysis validation using BioView Duet-3 System	1
96. Dissection of the expressed actionable fusions' repertoire in solid tumors in a clinical setting across 14 cancer types	1
Myeloid neoplasms with mutated KIT: comparative clinicopathologic analysis of D816 vs. non-D816 variants	1
131. Clonal Hematopoiesis is associated with risk of Cardiovascular Disease in individuals with Human Immunodeficiency Virus	1
WDR54 enhances NF-κB signaling to promote progression of hepatocellular carcinoma	1
53. Clinical whole exome/whole transcriptome (WES/WTS) analysis detects copy number and structural rearrangements important	1
Identification and characterization of ADAR1 mutations and changes in gene expression in human cancers	0
Molecular Landscape in Pediatric and Young Adult Thyroid Cancer: A Brazilian Cohort Study	0
67. An undiagnosed chronic myeloid leukemia (CML) with p190 BCR::ABL1 transcript, an extra Philadelphia chromosome, and IKARO	0
19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder	0
Editorial Board	0
Influence of germline test results on surgical decision making in women with invasive breast cancer	0
BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening	0
Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis	0